FDA Launches 'Elsa' AI Tool to Enhance Staff Efficiency in Regulatory Processes
DrugMedical Device

FDA Launches ‘Elsa’ AI Tool to Enhance Staff Efficiency in Regulatory Processes

FDA Launches Immediate Review of Clinical Trials Involving Cell Transfer to Hostile Countries
DrugPolicy / Regulatory

FDA Launches Immediate Review of Clinical Trials Involving Cell Transfer to Hostile Countries

Gilead's Yeztugo Approved by FDA as First Six-Monthly Injectable HIV PrEP
CompanyDrug

Gilead’s Yeztugo Approved by FDA as First Six-Monthly Injectable HIV PrEP

Fosun Pharma's Fumaining Launches Clinically for Rare Disease Treatment in China
CompanyDrug

Fosun Pharma’s Fumaining Launches Clinically for Rare Disease Treatment in China

FDA Launches Commissioner’s National Priority Voucher Program for Accelerated Drug Reviews
DrugPolicy / Regulatory

FDA Launches Commissioner’s National Priority Voucher Program for Accelerated Drug Reviews

Hengrui Pharma's Ruitanning Enters Clinical Use for Chemo-Induced Nausea and Vomiting
CompanyDrug

Hengrui Pharma’s Ruitanning Enters Clinical Use for Chemo-Induced Nausea and Vomiting

MSD's Clesrovimab Gears Up for Priority Review in China for RSV Prevention
CompanyDrug

Merck’s Clesrovimab Gears Up for Priority Review in China for RSV Prevention

Sanofi's Tzield Prescribed in Boao Lecheng to Delay Onset of Type 1 Diabetes
CompanyDrug

Sanofi’s Tzield Prescribed in Boao Lecheng to Delay Onset of Type 1 Diabetes

Allgens Medical's SkuHeal Artificial Bone Repair Material Gains Vietnam Marketing Approval
CompanyMedical Device

Allgens Medical’s SkuHeal Artificial Bone Repair Material Gains Vietnam Marketing Approval

Clover Biopharmaceuticals Completes Enrollment for Phase I Trial of RSV + hMPV Combination Vaccines
CompanyDrug

Clover Biopharmaceuticals Completes Enrollment for Phase I Trial of RSV + hMPV Combination Vaccines

Shanghai Henlius Biotech Partners with Shanghai Chest Hospital for Clinical Research and Talent Development
CompanyDeals

Shanghai Henlius Biotech Partners with Shanghai Chest Hospital for Clinical Research and Talent Development

RemeGen's Telitacicept Receives Orphan Drug Designation for Myasthenia Gravis in Europe
CompanyDrug

RemeGen’s Telitacicept Receives Orphan Drug Designation for Myasthenia Gravis in Europe